Lyon, France

Damien Simons

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignee: Sofradim Production. Active years: 2016-2026.

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Lyons, FR (2016 - 2022)
  • Trevoux, FR (2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Damien Simons: Innovator in Surgical Textiles

Introduction

Damien Simons is a notable inventor based in Lyon, France. He has made significant contributions to the field of surgical textiles, holding a total of 6 patents. His work focuses on innovative solutions for medical applications, particularly in soft tissue repair.

Latest Patents

One of Damien's latest patents is for a surgical textile with barbs and loops. This invention relates to a biocompatible textile that features an arrangement of yarns, with one face having a plurality of barbs and loops. The design allows for enhanced functionality in surgical applications. Another significant patent involves implants suitable for soft tissue repair. This patent describes an implantable web that includes a combination of laid yarns and threading yarns, providing effective solutions for hernia or prolapse repair.

Career Highlights

Throughout his career, Damien has worked with reputable companies such as Sofradim Production and Deltaval. His experience in these organizations has contributed to his expertise in the development of innovative medical textiles.

Collaborations

Damien has collaborated with notable professionals in his field, including Nizar Bechir and Thierry Brune. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Damien Simons is a pioneering inventor whose contributions to surgical textiles are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…